Michael John Ackerman, MD, PhD, FACC

  • 34761 Citations
  • 103 Scopus h-Index
1991 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Michael John Ackerman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Long QT Syndrome Medicine & Life Sciences
Hypertrophic Cardiomyopathy Medicine & Life Sciences
Mutation Medicine & Life Sciences
Sudden Cardiac Death Medicine & Life Sciences
Cardiac Arrhythmias Medicine & Life Sciences
Genetic Testing Medicine & Life Sciences
Channelopathies Medicine & Life Sciences
Sudden Death Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2002 2020

Exercise in Genetic Cardiovascular Conditions

Day, S., Lampert, R. & Ackerman, M. J.

National Institutes of Health

2/1/151/31/20

Project: Research project

Exercise
Quality of Life
Long QT Syndrome
Sports
Patient Advocacy
Sudden Infant Death
Mutation
Autonomic Nervous System
Genes
Macromolecular Substances

Research Output 1991 2019

2 Citations (Scopus)

2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary

Towbin, J. A., McKenna, W. J., Abrams, D. J., Ackerman, M. J., Calkins, H., Darrieux, F. C. C., Daubert, J. P., de Chillou, C., DePasquale, E. C., Desai, M. Y., Estes, N. A. M., Hua, W., Indik, J. H., Ingles, J., James, C. A., John, R. M., Judge, D. P., Keegan, R., Krahn, A. D., Link, M. S. & 10 others, Marcus, F. I., McLeod, C. J., Mestroni, L., Priori, S. G., Saffitz, J. E., Sanatani, S., Shimizu, W., van Tintelen, J. P., Wilde, A. A. M. & Zareba, W., Nov 2019, In : Heart rhythm. 16, 11, p. e373-e407

Research output: Contribution to journalArticle

Open Access
Risk Management
Cardiomyopathies
Arrhythmogenic Right Ventricular Dysplasia
Cardiac Arrhythmias
Heart Valve Diseases
9 Citations (Scopus)

2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy

Towbin, J. A., McKenna, W. J., Abrams, D. J., Ackerman, M. J., Calkins, H., Darrieux, F. C. C., Daubert, J. P., de Chillou, C., DePasquale, E. C., Desai, M. Y., Estes, N. A. M., Hua, W., Indik, J. H., Ingles, J., James, C. A., John, R. M., Judge, D. P., Keegan, R., Krahn, A. D., Link, M. S. & 10 others, Marcus, F. I., McLeod, C. J., Mestroni, L., Priori, S. G., Saffitz, J. E., Sanatani, S., Shimizu, W., van Tintelen, J. P., Wilde, A. A. M. & Zareba, W., Nov 2019, In : Heart rhythm. 16, 11, p. e301-e372

Research output: Contribution to journalArticle

Open Access
Risk Management
Cardiomyopathies
Arrhythmogenic Right Ventricular Dysplasia
Cardiac Arrhythmias
Heart Valve Diseases
1 Citation (Scopus)
Filamins
Mitral Valve Prolapse
Mothers
Exome
Ambulatory Monitoring
2 Citations (Scopus)
Monovalent Cations
L-Type Calcium Channels
Missense Mutation
Nifedipine
Bradycardia
1 Citation (Scopus)

Assessment and Validation of a Phenotype-Enhanced Variant Classification Framework to Promote or Demote RYR2 Missense Variants of Uncertain Significance

Giudicessi, J. R., Lieve, K. V. V., Rohatgi, R. K., Koca, F., Tester, D. J., van der Werf, C., Martijn Bos, J., Wilde, A. A. M. & Ackerman, M. J., May 1 2019, In : Circulation. Genomic and precision medicine. 12, 5, p. e002510

Research output: Contribution to journalArticle

Phenotype
Genetic Testing
Multicenter Studies
Retrospective Studies
Guidelines